tiprankstipranks
Trending News
More News >
Oxford Biomedica (otc) (OXBDF)
OTHER OTC:OXBDF
US Market

Oxford BioMedica (OXBDF) Financial Statements

Compare
64 Followers

Oxford BioMedica Financial Overview

Oxford BioMedica's market cap is currently $1.19B. The company's EPS TTM is $; its P/E ratio is -22.20; Oxford BioMedica is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24Dec 23Dec 22Dec 21Dec 20
Income Statement
Total Revenue£ 128.80M£ 89.54M£ 139.99M£ 142.80M£ 87.73M
Gross Profit£ 53.02M£ 39.73M£ 69.18M£ 82.64M£ 46.07M
Operating Income£ -39.38M£ -184.17M£ -30.22M£ 20.77M£ -5.69M
EBITDA£ -14.33M£ -148.62M£ -10.80M£ 33.22M£ 3.92M
Net Income£ -43.19M£ -157.49M£ -39.16M£ 19.01M£ -6.25M
Balance Sheet
Cash & Short-Term Investments£ 60.65M£ 103.72M£ 141.31M£ 109.02M£ 46.98M
Total Assets£ 231.64M£ 252.34M£ 460.18M£ 237.23M£ 183.93M
Total Debt£ 108.76M£ 111.46M£ 114.28M£ 9.34M£ 13.85M
Net Debt£ 48.11M£ 7.74M£ -27.00M£ -99.60M£ -32.90M
Total Liabilities£ 171.16M£ 174.51M£ 223.99M£ 49.89M£ 71.18M
Stockholders' Equity£ 57.05M£ 74.01M£ 204.65M£ 187.34M£ 112.75M
Cash Flow
Free Cash Flow£ -58.12M£ -38.35M£ -28.91M£ 15.99M£ -10.24M
Operating Cash Flow£ -50.63M£ -28.52M£ -12.62M£ 25.45M£ 3.12M
Investing Cash Flow£ 5.63M£ 2.81M£ -56.46M£ -9.46M£ -10.80M
Financing Cash Flow£ 2.91M£ -12.70M£ 98.62M£ 46.21M£ 38.19M
Currency in GBP

Oxford BioMedica Earnings and Revenue History

Oxford BioMedica Debt to Assets

Oxford BioMedica Cash Flow

Oxford BioMedica Forecast EPS vs Actual EPS